Baidu
map
BIOENGINEERED 润色咨询

Bioengineered

出版年份:暂无数据 年文章数:1792 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:8.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2023-04-16 qqqppp 来自北京

    投稿命中率:95.0
    偏重的研究方向:水刊
    经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2024-03-02 148b8695m26暂无昵称 来自广东省

    最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2021-08-28 SCI-1

    偏重的研究方向:生物工程
    经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2023-05-26 qqqppp 来自北京

    偏重的研究方向:水刊
    经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com)

    11

    展开11条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2023-05-26 科研小黑 来自湖北省

    不退稿费,该如何申诉?

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2023-01-05 ms4000001834233513 来自湖北省

    23年有这个杂志消息吗

    26

    展开26条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2023-10-17 ms3000000969299905

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2021-05-29 12368e7em59(暂无昵称)

    有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿

    55

    展开55条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2023-02-02 pendrin_89355954 来自广东省

    各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2126319, encodeId=2e692126319bd, content=投稿命中率:95.0<br>偏重的研究方向:水刊<br>经验分享:现在杂志不收录了,之前接收的全部撤稿,发邮件要姓名和电话,最终也不给退费,一年内被踢出s c i, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Sun Apr 16 17:36:52 CST 2023, time=2023-04-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190585, encodeId=ff1c2190585e2, content=最近这个杂志撤稿几十篇,又收回撤稿道歉十几个。搞什么呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf75325044, createdName=148b8695m26暂无昵称, createdTime=Sat Mar 02 12:27:59 CST 2024, time=2024-03-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1012318, encodeId=b46e101231866, content=偏重的研究方向:生物工程<br>经验分享:显示 loading your submissions failed !please try Again later 是怎么回事啊 系统崩溃了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76695510978, createdName=SCI-1, createdTime=Sat Aug 28 15:01:34 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139290, encodeId=82e22139290dc, content=偏重的研究方向:水刊<br>经验分享:文章接收后等了一年,没有任何明确原因撤稿,然后又拖仨月,说费用不给退。以下是他们的回复,流氓杂志和出版社。 在这种情况下,我很抱歉地通知您,由于您违反了作者保证和我们关于出版道德的编辑政策,您的**要求不符合我们的开放获取政策。 Taylor & Francis Open | Taylor & Francis Online (tandfonline.com), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452a2485614, createdName=qqqppp, createdTime=Fri May 26 22:05:50 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139287, encodeId=5302213928e55, content=不退稿费,该如何申诉?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Fri May 26 21:31:49 CST 2023, time=2023-05-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2108980, encodeId=58f32108980be, content=23年有这个杂志消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cfb6538540, createdName=ms4000001834233513, createdTime=Thu Jan 05 21:21:35 CST 2023, time=2023-01-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163431, encodeId=4df5216343104, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:19 May 2023 Manuscript Submitted 20 May 2023 With Journal Administrator 05 July 2023 With Editor 06 July 2023 Out for Review 11 July 2023 Reviews Complete 09 August 2023 Decision Pending 09 August 2023 Revision Required (major) 24 August 2023 Revision Incomplete 24 August 2023 Revised Manuscript Submitted 24 August 2023 With Journal Administrator 31 August 2023 With Editor 04 September 2023 Out for Review 04 September 2023 Reviews Complete 13 September 2023 Decision Pending 13 September 2023 Revision Required (minor) 18 September 2023 Revision Incomplete 18 September 2023 Revised Manuscript Submitted 28 September 2023 With Journal Administrator 28 September 2023 Decision Pending 28 September 2023 With Editor 03 October 2023 Out for Review 16 October 2023 Accpeted 编辑和审稿人比较友好,但是编辑部的配稿处理非常慢,历时五个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c278403615, createdName=ms3000000969299905, createdTime=Tue Oct 17 23:38:26 CST 2023, time=2023-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969421, encodeId=9fe7969421a3, content=有没有人遇到这种情况,投稿的时候,在charges部分一直提示“invalid billing address,please provide valid address”,卡在这最后一步无法投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38912407074, createdName=12368e7em59(暂无昵称), createdTime=Sat May 29 12:43:19 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112694, encodeId=f52c21126940c, content=各位医生同学,我想问下,你们知道Bioengineered是什么意思吗?你们治病救人、研究癌症,研究小RNA,跟Bioengineered有什么关系?为什么往这里投?你难道不是心知肚明?你们把对方投死了,有什么好抱怨的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Feb 02 09:21:07 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153248, encodeId=c8dc215324877, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzB8KTw5fRddzkAb6hN75KWHXVlmRnX8Eoug6WeMSwYsdm2O7oSrbf0tg7grLicrfNs7LNrTNhHNg/132, createdBy=f9d82046571, createdName=123456八成的, createdTime=Thu Aug 17 15:46:09 CST 2023, time=2023-08-17, status=1, ipAttribution=新加坡)]
    2023-08-17 123456八成的 来自新加坡

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享:有版面费没退的,建议联系Elisabeth Bik。还有负责影响因子的团队。把这个杂志社的欺诈情况跟他们说一下。要引起舆论的注意,国内的肯定不行,帮不了什么。这种杂志社如果想挣钱,一定会重视这的。你们一起

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map